/Investor DB

CPT Capital — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

BioRaptorbioraptor.aiinApr 2024

BioRaptor provides a bioprocess data management platform that stores and analyzes biological metrics to help biotechnology teams move from trial-and-error to optimized experimentation.

AI & Machine LearningBiotechData & Infrastructure

Co-investorsCrane Venture PartnersLool VenturesColler CapitalGood Startup

Mozzamozzafoods.comin𝕏Mar 2024

Mozza Foods develops casein protein grown in soybeans as an ingredient for the dairy industry, aiming to replace cow-dependent supply chains using existing agricultural infrastructure.

AgTechBiotechFoodTechLos Angeles, US

Adam Tarshis(Founder)inNatasha Sharma(Director)

BoardRose Eva Wardle(Director)

Co-investorsAlumni VenturesLever VCStray Dog CapitalSynthesis CapitalTrue VenturesVegInvest

Prolific Machinesprolific-machines.cominMay 2024

Prolific Machines licenses an optogenetics platform that adds light-based control to cell line development and GMP biomanufacturing, letting biopharma teams retrofit existing bioreactors and hosts to raise titers and manufacture complex molecule formats.

Advanced ManufacturingAI & Machine LearningBiotechDeep TechEmeryville, US

Maximilian HörnerinMax Huisman(Founder)inDeniz Kent(Founder)inDeniz Kent, Ph.D.(Founder)inDeclan Jones(Founder)inShahram Misaghiin

Co-investorsBaruch Future VenturesBreakthrough Energy VenturesDarco CapitalIn-Q-TelMayfield FundSolari Capital+3 more

Shirushiru.comin𝕏Series B · Nov 2024

Shiru uses AI and material science to discover natural proteins and ingredients for use in food, personal care, agriculture, and advanced materials, reducing traditional development timelines from 5-15 years to 1-2 years.

AI & Machine LearningBiotechFoodTechHealthtechEmeryville, US

Jasmin Hume(Founder)inLawrence Lee(CTO)Geoffroy Dubourg-Felonneau(Machine Learning Lead)

Co-investorsEmles Venture PartnersGaingelsLux CapitalNourish VenturesS2G InvestmentsSGH Capital+12 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.